3.95
Sensus Healthcare Inc stock is traded at $3.95, with a volume of 20,805.
It is down -0.38% in the last 24 hours and up +7.45% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$3.98
Open:
$4.03
24h Volume:
20,805
Relative Volume:
0.20
Market Cap:
$64.88M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
6.9298
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
-5.37%
1M Performance:
+7.45%
6M Performance:
-21.17%
1Y Performance:
-55.45%
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare Inc
|
3.95 | 66.03M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
125.34 | 218.05B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.04 | 144.86B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
365.55 | 139.34B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
102.00 | 130.75B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.81 | 49.78B | 5.88B | 1.34B | 799.60M | 2.3489 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Will Sensus Healthcare Inc. stock continue dividend increasesTrade Entry Report & AI Driven Stock Price Forecasts - moha.gov.vn
Will Sensus Healthcare Inc. stock deliver long term returns2025 Sector Review & Smart Swing Trading Alerts - BỘ NỘI VỤ
Will Sensus Healthcare Inc. stock benefit from AI adoptionQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - BỘ NỘI VỤ
These Analysts Think Sensus Healthcare, Inc.'s (NASDAQ:SRTS) Earnings Are Under Threat - Yahoo Finance
Sensus Healthcare (NASDAQ:SRTS) Downgraded to Sell Rating by Wall Street Zen - Defense World
Sachetta Eric buys $27k in Sensus Healthcare shares By Investing.com - Investing.com South Africa
Sachetta Eric buys $27k in Sensus Healthcare shares - Investing.com
Sachetta Eric buys $11k in Sensus Healthcare (SRTS) By Investing.com - Investing.com Australia
Will Sensus Healthcare Inc. stock see insider buying2025 Trading Recap & Fast Exit and Entry Strategy Plans - newser.com
How hedge fund analytics apply to Sensus Healthcare Inc. stockBreakout Watch & Comprehensive Market Scan Reports - newser.com
Sachetta Eric buys $11k in Sensus Healthcare (SRTS) - Investing.com
How currency fluctuations impact Sensus Healthcare Inc. stockWeekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Is Sensus Healthcare Inc. stock supported by strong fundamentalsMarket Volume Report & Smart Money Movement Alerts - newser.com
How resilient is Sensus Healthcare Inc. stock in market downturnsDip Buying & Technical Confirmation Trade Alerts - newser.com
Sensus Healthcare director Sardano buys $3.8k in shares By Investing.com - Investing.com Canada
Sensus Healthcare CEO Sardano buys $100k in company stock By Investing.com - Investing.com Canada
Sensus Healthcare Stock (SRTS) Opinions on Insider Buying and Strategic Updates - Quiver Quantitative
Is Sensus Healthcare Inc. stock a buy before product launches2025 Market Outlook & Community Verified Trade Alerts - newser.com
Insider Buying: Joseph Sardano Acquires 25,000 Shares of Sensus Healthcare Inc (SRTS) - GuruFocus
Sensus Healthcare director Sardano buys $3.8k in shares - Investing.com
Sensus Healthcare, Inc. (NASDAQ:SRTS) Stock Rockets 26% But Many Are Still Ignoring The Company - simplywall.st
Can Sensus Healthcare Inc. stock beat analyst upgrades2025 Technical Patterns & Risk Controlled Swing Alerts - newser.com
Real time pattern detection on Sensus Healthcare Inc. stockMarket Performance Summary & Fast Entry Momentum Alerts - newser.com
[Form 4/A] Sensus Healthcare, Inc. Amended Insider Trading Activity - Stock Titan
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade - MSN
Why Sensus Healthcare Inc. stock could see breakout soonEarnings Overview Report & Comprehensive Market Scan Insights - newser.com
Sensus Healthcare Inc. stock outlook for YEARExit Point & Momentum Based Trading Ideas - newser.com
Why Sensus Healthcare Inc. stock could rally in 20252025 Valuation Update & Fast Moving Stock Trade Plans - newser.com
Published on: 2025-11-16 02:05:46 - newser.com
Sensus Healthcare appoints Michael Sardano as chief commercial officer By Investing.com - Investing.com Nigeria
Can Sensus Healthcare Inc. stock attract ESG capital inflows2025 Momentum Check & Real-Time Buy Signal Alerts - Fundação Cultural do Pará
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
| Rampolla Javier | CHIEF FINANCIAL OFFICER |
Feb 10 '25 |
Buy |
5.95 |
501 |
2,981 |
40,745 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Feb 10 '25 |
Buy |
5.95 |
1,000 |
5,950 |
115,839 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):